INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 280
RESEARCH DOSSIER / NOT AN ENDORSEMENT

REMEVi

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'GLP-1 weight loss · English & Spanish. A little less weight. A lot more you.' Personalized medical weight loss, one clear price, support in your language. 'One price at every dose. No dose upcharge, no membership.'

Audienceread

US weight-loss patients including Spanish-speaking consumers; 49 states + DC.

Pricing & termssnapshot

Semaglutide injection from $159/4wk (24-week plan; $169 on 12-week, $199 monthly); tirzepatide from $225/4wk ($233/$269); oral semaglutide from $215/4wk ($229/$249). Price never increases with dose; no membership fee; labs, supplies and shipping included.

Clinical relationshipspartial

Clinician evaluation and follow-up included; clinician must be licensed in the patient's state; GLP-1 lab tests required by the clinician included.

Pharmacy & fulfillmentpartial

Medication, supplies and shipping included; pharmacy not named. Not available in Louisiana.

Advertising snapshotpartial

No attributable ads found in Google, Meta or LinkedIn public libraries on 20 Oct 2026. See dated channel evidence.

Founding yearnot_found

Not established; active 2026 launch newsroom per discovery pass.

    Foundersnot_found

    Not found in this pass.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.